Second line therapy for nsclc
Small Cell Lung Cancer Clinical T-Stage, N0-N3 M0 SCLC From: Shepherd FA, Crowley J, Van Houtte P et al. The IASLC lung cancer staging project: proposals.
A Randomized, Double-blind, Placebo-controlled, Phase IIIb Trial (ATLAS) Comparing Bevacizumab Therapy with or without Erlotinib, after Completion of Chemotherapy.
New Perspectives on Second-Line Therapy for NSCLC Tony Mok, MD (Moderator) Professor, Department of Clinical Oncology, Chinese University of Hong Kong;
